Sharecare price target raised to $1.43 from $1 at Morgan Stanley

Morgan Stanley analyst Craig Hettenbach raised the firm’s price target on Sharecare to $1.43 from $1 and keeps an Equal Weight rating on the shares after the company agreed to sell itself to healthcare investment firm Altaris. The firm views the deal as “a good outcome for SHCR holders” in the context of the company’s fundamental struggles and stock performance setbacks since the de-SPAC, the analyst tells investors.